We're searching for individuals who have been alerted to potential heart health issues by a medical professional due to elevated cholesterol levels.
High cholesterol can increase the risk of heart disease.
If you've got high cholesterol, you could help us with a Clinical study. We're testing a new medicine you take twice a year that might lower your chance of heart problems in the future.
Researchers are conducting a new clinical research study designed to see if an investigational drug helps reduce the risk of future cardiovascular events, such as heart attacks and strokes. You may be qualified to join if you are 40 years of age or older and are at risk for heart disease. The goal of the study is to see if an investigational drug that lowers bad cholesterol levels (LDL-C) may reduce the risk of cardiovascular events such as heart attacks, strokes or heart bypass surgery /coronary artery stent procedures. You will be closely monitored by the study team. Participation is voluntary.
If you're 40 or older and at high risk for cardiovascular disease, consider joining our clinical study spanning 3-5 years. The first year involves 4 visits, followed by 2 annual visits, concluding with a phone check-in. Each visit includes health assessments, tests, study drug administration, and questionnaires. Participation is voluntary and offers a chance to contribute to groundbreaking research. For eligibility and further details, consult your study doctor.
"Joining this study was a decision I'm proud of. Not only did I get access to cutting-edge treatments, but I also felt like I was contributing to a bigger cause. The team was supportive throughout."
Participant, Shoulder Pain Study
"I was initially hesitant, but the detailed information and the professional team put my worries to rest. The added oversight of my health was a bonus. I recommend this study to others."
Volunteer, Health Research Advocacy
"Being a part of this research felt empowering. The potential to help others in the future and the attentive care I received made the experience worthwhile."
Member, Patient Rights Organization
Participating in our clinical study offers potential benefits and risks. By joining, you could advance research to aid others with the same disease, access treatments not yet available publicly, and receive enhanced healthcare oversight. However, there might be unknown side effects, the treatment might not be effective for you, and additional doctor visits and tests may be required. The investigational drug and specific study procedures come at no cost to you. Additionally, compensation for travel and related expenses might be available. For a comprehensive understanding of benefits, risks, and compensation, please consult your study doctor
Dr. Dennis J. Levinson is a Clinical Associate Professor of Medicine at the University of Illinois, Chicago. He received his undergraduate education at the University of Illinois and attended the Rosalind Franklin University (formerly Chicago Medical School). After completing his residency at Michael Reese Hospital and serving in the military, he finished his fellowship in rheumatology at the University of Chicago.
Dr. Levinson has been practicing rheumatology for 40 years. He is board certified in Internal Medicine and Rheumatology, and a Founding Fellow of the American College of Rheumatology. He is a past president of the Chicago Rheumatism Society and served as Chief of Service and Program Director of Internal Medicine at Michael Reese Hospital in Chicago from 1999 to 2008. He currently sits on the board of the Michael Reese Research and Education Foundation, which focuses on funding scholarships, community healthcare, and research.
Dr. Levinson has contributed to the medical literature with over 74 articles, abstracts and book chapters and continues to participate in clinical research. He was also involved in the first stem cell transplant for sickle cell disease in the Chicago area. In 2016, he received the Hispanocare Outstanding Community Award for scholarship support in the Latino community.
cardiovascular event
having a major cardiovascular
event in the future
The study aims to explore the effectiveness of an investigational drug in reducing the risk of cardiovascular events in individuals aged 40 and above.
No, participants will not bear any costs for the investigational drug or specific study procedures. Additionally, compensation for travel and related expenses might be available.
The study spans between 3 to 5 years, with varying numbers of visits each year, concluding with a phone check-in towards the end.
Monday to Friday
Join our clinical
research study and see if an investigational drug helps reduce the risk of
cardiovascular events.
© Copyright 2023 - All Rights Reserved